Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors
7 months, 2 weeks ago

Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors

The Hindu  

At a time when the safety aspects of the Covishield vaccine have kicked up a row, a retrospective study by two doctors from Kozhikode has claimed that its risks are minimal in view of the benefits. The controversy arose after pharmaceutical company AstraZeneca admitted in the High Court of London, United Kingdom, that its vaccine against COVID-19 had the potential to cause thrombosis with thrombocytopenia syndrome, a rare side-effect associated with blood clotting in the brain. The study examined the severe adverse reactions reported between January 16, 2021, when the vaccine was launched in the country, and May 17, 2022. A total of 3,023 adverse reactions, including allergic reactions, blood clotting, and cardiovascular events, were reported, according to government data. Dr. Jayakrishnan pointed out that vaccine-induced thrombocytopenia in European countries was reported to be four per one million.

India Vaccine Kozhikode Reactions Adverse Covishield  kozhikode  study  million  india  vaccine  risks  vaccineinduced  benefits  covishield  total  reported  thrombocytopenia  reactions  doctors  adverse

History of this topic

One more shot: vaccines, counters and flip flops
7 months ago

One more shot: vaccines, counters and flip flops

The Hindu  

We wondered if the sordid vaccine issue had been set to rest, last week, but that is not to be. “ICMR cannot be associated with this poorly designed study,” the director general’s letter says, and calls for an immediate retraction of the hat tip to ICMR from the article, and publish an Erratum. Also, it does not mention how frequently …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021
7 months, 2 weeks ago

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021

New Indian Express  

NEW DELHI: Days after AstraZeneca admitted for the first time in court documents that their Covid-19 vaccine can cause a rare and dangerous side effect, the British pharma giant announced that they are withdrawing it globally. In its statement, AstraZeneca said, "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. According to …

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
7 months, 3 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

Covishield more effective than Covaxin: Study
9 months, 2 weeks ago

Covishield more effective than Covaxin: Study

New Indian Express  

BENGALURU: Covishield vaccine had higher antibody response compared to Covaxin during the pandemic, according to a study by a consortium of 11 institutions led by scientists from the National Centre for Biological Sciences, Bengaluru. In all, 691 people aged between 18 and 45, mostly from Bengaluru and Pune, were part of the study.’Immunogenicity of SARS - CoV-2 vaccines Covaxin and …

What study on Covishield versus Covaxin vaccine reveals
9 months, 2 weeks ago

What study on Covishield versus Covaxin vaccine reveals

The Hindu  

March 07, 2024 10:59 am | Updated March 09, 2024 10:53 am IST - Bengaluru A new study by a consortium of 11 institutes, led by scientists from the National Centre for Biological Sciences, has found that the Covishield vaccine demonstrated more robust immune responses compared to Covaxin. The key findings state that Covishield, leveraging a virus vector to deliver …

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects
1 year, 10 months ago

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects

Live Mint  

A well known British-Indian cardiologist has flagged the cardiovascular side effects of the Covishield vaccine. According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes. Citing a comparison published in a peer-reviewed journal, he said that the Oxford-AstraZeneca …

SII stopped Covishield production last year; says Adar Poonawalla; claims nearly 100 million doses expired
2 years, 2 months ago

SII stopped Covishield production last year; says Adar Poonawalla; claims nearly 100 million doses expired

India TV News  

Highlights Adar Poonawalla said SII halted the production of vaccines in December 2021 Booster vaccines have no demand, Adar Poonawalla said There is general lethargy among people and they are fed up with the pandemic, Poonawalla said Serum Institute of India has stopped the production of the Covishield vaccine as there are not many takers for COVID-19 booster doses. The …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients

Live Mint  

Hyderabad-based Biological E has submitted an application to India's drug regulator, seeking emergency use authorisation for its Covid-19 vaccine Corbevax as a booster dose for adults who have been given two doses of either Covishield or Covaxin, reported news agency PTI, quoting sources. “We are now submitting the marketing authorization application for grant of permission Corbevax for restricted use in …

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet
2 years, 9 months ago

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet

News 18  

The National Technical Advisory Group on Immunisation has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, officials said on Sunday. Under the National Covid-19 Vaccination Strategy, the second dose of Covishield is to be given between 12-16 weeks after the first dose. An official source said the latest recommendation of …

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16
2 years, 9 months ago

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16

India TV News  

Highlights NTAGI recommended administering 2nd dose of Covishield between 8-16 weeks after the first dose. Presently, the second dose of Covishield is given between 12-16 weeks after the first dose. India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday …

Covishield as Booster After 2 Doses of Covaxin Increases Antibodies by 6 Times: Study
2 years, 9 months ago

Covishield as Booster After 2 Doses of Covaxin Increases Antibodies by 6 Times: Study

News 18  

A recent study has found that Covishield is more effective when administered as a booster after two doses of Covaxin as antibodies zoom six-fold, however, the case is not the same when the vaccines are reversed. The study, submitted by Christian Medical College, Vellore, to the Drugs Controller General of India on Wednesday, is the first preliminary scientific evidence from …

Pune: 1.24 lakh Covishield vaccines will expire within 38 days, says municipal corporation report
2 years, 10 months ago

Pune: 1.24 lakh Covishield vaccines will expire within 38 days, says municipal corporation report

India Today  

A recent Pune Municipal Corporation report has revealed that a total of 1.24 lakh Covishield vaccine doses are lying at 22 private vaccination centres and hospitals within the Pune municipal limits. Of the total 1.24 lakh jabs, about 1.09 lakh doses are lying at Jupiter hospital, which are expected to expire on March 5. 1.24 lakh Covishield vaccines to face …

Most vulnerable still in jeopardy as COVID precautions ease
2 years, 10 months ago

Most vulnerable still in jeopardy as COVID precautions ease

Associated Press  

Two years into the pandemic Jackie Hansen still left home only for doctor visits, her immune system so wrecked by cancer and lupus that COVID-19 vaccinations couldn’t take hold. While healthy vaccinated people may return to pre-pandemic activities with little worry about severe consequences, “the immunocompromised -- despite vaccination, despite taking all precautions -- cannot, and remain at risk.” “We’re …

Covishield could soon be available at medical stores as SII seeks full market authorisation nod
2 years, 11 months ago

Covishield could soon be available at medical stores as SII seeks full market authorisation nod

India TV News  

Pune-based Serum Institute of India has applied for full market authorisation for the COVID-19 vaccine Covishield with the drug regulator. SII CEO Adar Poonawala confirmed that the institute has applied for full market authorisation of the drug, stating supplies of the COVID-19 vaccine have exceeded 125 crore doses. The institute had earlier this month sought the drug regulator's approval for …

Expert Advice Based On Scientific Study Cannot Be Substituted By A Judgment Of Constitutional Courts: Kerala HC While Upholding 84 Days Dose Interval For Covishield
3 years ago

Expert Advice Based On Scientific Study Cannot Be Substituted By A Judgment Of Constitutional Courts: Kerala HC While Upholding 84 Days Dose Interval For Covishield

Live Law  

Reversing a Single Judge decision, the Kerala High Court on Friday delivered a significant decision ruling that the second dose of the COVISHIELD vaccine can only be administered after the prescribed dose interval of 84 days. In its 94-paged judgment, a Division Bench of Chief Justice S Manikumar and Justice Shaji P Chaly has elaborated on why the decision of …

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave
3 years ago

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The Covishield vaccine was effective …

Second dose of Covid vaccine overdue for over 11 crore people: Govt data
3 years, 1 month ago

Second dose of Covid vaccine overdue for over 11 crore people: Govt data

Live Mint  

Over 11 crore people who have taken the first shot of COVID-19 vaccine have not got themselves jabbed with the second dose even after the expiry of the prescribed interval between two doses, according to government data. The data showed that over 3.92 crore beneficiaries are more than six weeks overdue for their second dose, around 1.57 crore are up …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days
3 years, 3 months ago

'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days

Live Law  

The Centre has preferred an appeal before the Kerala High Court against a Single Bench order allowing the second dose of COVISHIELD to be administered prior to the prescribed interval of 84 days. The appeal has been filed through the Assistant Solicitor General of India P. Vijayakumar.By the aforesaid judgment, the Single bench had directed the appellants to make necessary …

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October
3 years, 3 months ago

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October

India Today  

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said. In a communication to the Centre on Monday, Prakash Kumar Singh, …

Covaxin data looks good, WHO nod expected by September-end: Dr VK Paul | Exclusive
3 years, 3 months ago

Covaxin data looks good, WHO nod expected by September-end: Dr VK Paul | Exclusive

India Today  

As India crossed the landmark of administering 75 crore Covid-19 vaccine doses, Dr VK Paul, member of Niti Aayog and head of the Covid-19 task force, said India was well on its path in achieving complete vaccination of the entire adult population by the end of the year. ON BOOSTER DOSES Dr VK Paul also said that just yet there …

No Fundamental Rights Of Petitioner Infringed: Govt Responds To Plea Challenging 84 Days Dose Interval For Covishield Vaccines
3 years, 3 months ago

No Fundamental Rights Of Petitioner Infringed: Govt Responds To Plea Challenging 84 Days Dose Interval For Covishield Vaccines

Live Law  

The Secretary to the Government submitted its counter-affidavit before the Kerala High Court on Thursday responding to the petition that challenged the prescribed 84 days gap between administering two doses of the Covishield vaccine. Accordingly, it was argued that the dose interval between the two doses of the Covishield vaccine under the COVID-19 vaccination drive had undergone a series of …

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports
3 years, 3 months ago

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports

Firstpost  

In May, the Centre further extended the gap between two doses of Covishield from 6-8 weeks to 12-16 weeks and said it was based on scientific evidence New Delhi: Reducing the gap between two doses of Covishield is being considered and it will be discussed in the National Technical Advisory Group on Immunisation in India, official sources said on Thursday. …

Mixing of Covishield, Covaxin safe; elicits better immunity: ICMR study
3 years, 4 months ago

Mixing of Covishield, Covaxin safe; elicits better immunity: ICMR study

Live Mint  

Immunization with a combination of first dose of Covishield followed by second dose of Covaxin is not only safe but also elicits better immunogenicity, the Indian Council of Medical Research said on Sunday citing its preprint research. Covishield is the in-country version of the Oxford-AstraZeneca vaccine manufactured by Serum Institute of India, while Covaxin is an inactivated whole virus vaccine …

Increase in Gap Between Covishield Doses Based on Scientific Evidence: Govt
3 years, 4 months ago

Increase in Gap Between Covishield Doses Based on Scientific Evidence: Govt

News 18  

The recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the government informed Rajya Sabha on Tuesday. No dissent was raised by any member in the meeting of the National Technical Advisory Group on Immunisation regarding the recommendation, Minister of State for Health Bharati Pravin …

Covishield to only be used for administering second doses till July 31 in Delhi
3 years, 5 months ago

Covishield to only be used for administering second doses till July 31 in Delhi

India Today  

Delhi had less than a day's stock of coronavirus vaccine left on Thursday morning, prompting the government to issue an order stating that Covishield will only be used for administering second doses till July 31, according to a bulletin. A total of 48,256 vaccine doses were administered here on Thursday, taking the total number of doses given so far in …

5 people in MP came for Covaxin 2nd dose, given Covishield instead
3 years, 5 months ago

5 people in MP came for Covaxin 2nd dose, given Covishield instead

Hindustan Times  

Bhopal/Chhindwara: Five people were administered Covishield as the second dose instead of Covaxin at a vaccination centre in Madhya Pradesh’s Chhindwara district on Wednesday, said a state health department official. Chhindwara’s district immunisation officer LN Sahu said the mix-up happened because vaccination was being done without prior registration/ Chhindwara’s district immunisation officer LN Sahu confirmed the mix-up and stressed that …

Covishield, Covaxin, Sputnik V, Moderna vaccines safe for pregnant women, lactating moms: Dr VK Paul
3 years, 5 months ago

Covishield, Covaxin, Sputnik V, Moderna vaccines safe for pregnant women, lactating moms: Dr VK Paul

India Today  

Niti Aayog member Dr VK Paul on Tuesday said that four Covid-19 vaccines -- Covishield, Covaxin, Sputnik V and Moderna -- that have been approved by the government, are safe for lactating mothers and pregnant women, adding that an advisory with regards to their vaccination will be released soon. Vaccine is safe for pregnant women, and the Health Ministry is …

Covishield-EU issue: Adar Poonawalla says has taken this up at highest level
3 years, 5 months ago

Covishield-EU issue: Adar Poonawalla says has taken this up at highest level

Hindustan Times  

Serum Institute of India's Adar Poonawalla said on Monday he has spoken with authorities after the AstraZeneca-Oxford vaccine, which is being manufactured by his company, was excluded from the list of anti-Covid-19 shots that are eligible for the European Union's "Green Pass". According to news agency PTI, Serum Institute of India has produced over 100 million doses of Covishield in …

Serum Institute of India produces over 10 crore doses of Covishield in June
3 years, 5 months ago

Serum Institute of India produces over 10 crore doses of Covishield in June

India Today  

Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection. Read | Serum Institute begins manufacturing first batch of Covovax vaccine According to information provided to …

Covishield dose gap row: Harsh Vardhan says decision was taken unanimously; calls controversy 'unfortunate'
3 years, 6 months ago

Covishield dose gap row: Harsh Vardhan says decision was taken unanimously; calls controversy 'unfortunate'

Firstpost  

Covishield dose gap row: Union health minister Harsh Vardhan too said the decision to increase the gap “has been taken in a transparent manner based on scientific data” The government said on Wednesday the decision to increase the interval between two doses of Covishield to 12-16 weeks was based on scientific evidence, suggesting that authorities were discussing whether to reduce …

Covishield row: Health minister clarifies on decision to increase gap between vaccine doses
3 years, 6 months ago

Covishield row: Health minister clarifies on decision to increase gap between vaccine doses

Live Mint  

The decision to increase the gap between administering two doses of the Covid-19 vaccine, Covishield has been taken in a "transparent manner based on scientific data", Union Health Minister Dr Harsh Vardhan said on Wednesday. The Health Minister's statement comes amid concerns that the government had doubled the gap between the two doses of Covishield - from six-eight weeks to …

Decision on Covishield gap taken transparently, based on scientific evidence: Centre
3 years, 6 months ago

Decision on Covishield gap taken transparently, based on scientific evidence: Centre

India Today  

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday. Meanwhile, Union Health Minister Harsh Vardhan tweeted on Wednesday: "Decision to increase the gap between administering two doses of Covishield has been taken in a transparent manner based on scientific data. …

Covishield dose gap row: Change due to vaccine shortage or on scientific advice?
3 years, 6 months ago

Covishield dose gap row: Change due to vaccine shortage or on scientific advice?

India Today  

A row has erupted over the extension of the gap between two Covishield doses. Was the change made due to vaccine shortages or on scientific advice? India Today TV Consulting Editor Rajdeep Sardesai speaks to Dr NK Arora, Chairman of India's Covid-19 working group of the National Technical Advisory Group on Immunisation. Q: Can you assure that the decisions to …

AstraZeneca's Covishield Vaccine Linked with Small Risk of Low Blood Platelets: Study
3 years, 6 months ago

AstraZeneca's Covishield Vaccine Linked with Small Risk of Low Blood Platelets: Study

News 18  

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK. The study of 5.4 million people in Scotland, of whom 2.5 million had received their first vaccine dose, is the first analysis of ITP, clotting and …

Centre Places Order For 44 Cr Doses Of Covishield, Covaxin As PM Takes Over Vaccine Procurement From States
3 years, 6 months ago

Centre Places Order For 44 Cr Doses Of Covishield, Covaxin As PM Takes Over Vaccine Procurement From States

ABP News  

New Delhi: A day after Prime Minister Narendra Modi announced vaccination policy, the Union government on Tuesday said that it has placed orders for 44 crore doses of Covishield and Covaxin jabs to boost inoculation drive in the country. "In immediate follow-up of the prime minister's announcement of these changes in the Guidelines of National COVID Vaccination programme yesterday, the …

Centre places fresh orders for 44 crore doses of Covishield and Covaxin
3 years, 6 months ago

Centre places fresh orders for 44 crore doses of Covishield and Covaxin

The Hindu  

The Centre has placed fresh orders for 44 crore vaccine doses of Covishield and Covaxin which will be available from August-December. Until July, 53 crore vaccine doses — including 23.5 crore already administered — were expected from the two manufacturers Serum Institute of India and Bharat Biotech. If all the estimates were to come to fruition, it would mean 127 …

Coronavirus | Covishield produces more anti-bodies than Covaxin, says study
3 years, 6 months ago

Coronavirus | Covishield produces more anti-bodies than Covaxin, says study

The Hindu  

Two doses of Covishield vaccine produced more antibodies than Covaxin doses, but there were relatively fewer instances of ‘breakthrough infections’ after the latter, reports a study of healthcare workers in India. Ten-fold higher A single dose of Covishield elicited about 10 times the antibodies than Covaxin whereas a second dose narrowed the gap somewhat, with Covishield-triggered antibodies about six times …

No mixing of vaccines, everyone will get 2 doses of Covaxin, Covishield: Govt
3 years, 6 months ago

No mixing of vaccines, everyone will get 2 doses of Covaxin, Covishield: Govt

India Today  

The central government on Tuesday clarified that there will be no mixing of Covid-19 vaccine doses in India until enough scientific evidence on its effectiveness is gathered. These clarifications come amid concerns triggered by some recent comments made by senior officials indicating that the government may consider doing away with the second dose of Covishield. Apart from this, head of …

Centre planning new COVID-19 vaccine strategy; mulls single shot of Covishield, mixing doses
3 years, 6 months ago

Centre planning new COVID-19 vaccine strategy; mulls single shot of Covishield, mixing doses

Firstpost  

This gains significance coming in the backdrop of India, which is battling the second wave of the COVID-19 pandemic, facing a severe vaccine shortage From studying the effectiveness of a single dose of Covishield to mixing vaccines, the Centre is considering tweaking its vaccine strategy, according to several media reports. Government sources speaking to NDTV further said that Covishield originally …

India aims to procure around 25 cr Covid vaccine doses in two months: Report
3 years, 6 months ago

India aims to procure around 25 cr Covid vaccine doses in two months: Report

Live Mint  

Amid attempts to ramp up the Covid-19 vaccination drive in the country further, the Indian government on Sunday said that it targets to procure 20-25 crore coronavirus vaccine doses by July-end, and 30 crore doses in August-September, news agency ANI reported citing government sources. Pune-based Serum Institute of India will provide 10-12 crore doses of Covishield vaccine to Govt next …

Covishield Gap Reduced for Keralites Travelling Abroad, Govt to Issue Vaccine Docus with Passport Numbers
3 years, 6 months ago

Covishield Gap Reduced for Keralites Travelling Abroad, Govt to Issue Vaccine Docus with Passport Numbers

News 18  

The Kerala government on Friday decided to issue a Covid-19 vaccination certificate with passport numbers to those who require to travel abroad for purposes such as jobs or higher studies. According to the order, a person who took Covishield jab and wants to get travel clearance will be eligible for second dose after four to six weeks. Since currently Covid-19 …

Discover Related